New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Does catheter ablation lower dementia and mortality risks in all groups of older adults with atrial fibrillation?

Does catheter ablation lower dementia and mortality risks in all groups of older adults with atrial fibrillation?

by WileyCredit: CC0 Public DomainPrevious studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation. This procedur
Cardiovascular Diseases May 20,2024
Does catheter ablation lower dementia and mortality risks in all groups of older adults with atrial fibrillation?

Does catheter ablation lower dementia and mortality risks in all groups of older adults with atrial fibrillation?

by WileyCredit: CC0 Public DomainPrevious studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation. This procedur
Cardiovascular Diseases May 20,2024
Benefits of garlic extend to Alzheimer's

Benefits of garlic extend to Alzheimer's

by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
Neurology May 20,2024
Benefits of garlic extend to Alzheimer's

Benefits of garlic extend to Alzheimer's

by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
Neurology May 20,2024
When someone living with dementia is distressed or violent, 'de-escalation' is vital

When someone living with dementia is distressed or violent, 'de-escalation' is vital

by Steve Macfarlane,The ConversationCredit: AI-generated imageToday'sreportingabout the alleged tasering of a 95-year-old woman living at the Yallambee Lodge aged care home in Ne
Neurology May 20,2024
When someone living with dementia is distressed or violent, 'de-escalation' is vital

When someone living with dementia is distressed or violent, 'de-escalation' is vital

by Steve Macfarlane,The ConversationCredit: AI-generated imageToday'sreportingabout the alleged tasering of a 95-year-old woman living at the Yallambee Lodge aged care home in Ne
Neurology May 20,2024
Over 1.2 million people in England and Wales will be living with dementia by 2040

Over 1.2 million people in England and Wales will be living with dementia by 2040

by British Medical JournalCredit: CC0 Public DomainBy 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), largely due to increase
Neurology May 20,2024
Over 1.2 million people in England and Wales will be living with dementia by 2040

Over 1.2 million people in England and Wales will be living with dementia by 2040

by British Medical JournalCredit: CC0 Public DomainBy 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), largely due to increase
Neurology May 20,2024
A million Aussies will have dementia by 2056, so now is the time to act on prevention

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number
Neurology May 20,2024
A million Aussies will have dementia by 2056, so now is the time to act on prevention

A million Aussies will have dementia by 2056, so now is the time to act on prevention

by Cate Swannell, Medical Journal of AustraliaCredit: CC0 Public DomainDementia prevention needs to be Australia's next public health area of focus, as the nation heads towards a projected number
Neurology May 20,2024
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Washington University School of Medicine in St. Louis have identified proteomic changes associated with forms of Alzhe
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Big data initiative discovers new causal pathways in Alzheimer's

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single brain scan can diagnose Alzheimer's disease

Single brain scan can diagnose Alzheimer's disease

by Imperial College LondonPET scan of a human brain with Alzheimer's disease. Credit: public domainThe research uses machine learning technology to look at structural features within the brai
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
Single dual time-point PET scan identifies dual Alzheimer's biomarkers

Single dual time-point PET scan identifies dual Alzheimer's biomarkers

by Society of Nuclear MedicineWhile subject #1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in
Neurology May 20,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com